Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.05)
# 2,836
Out of 4,835 analysts
474
Total ratings
36.65%
Success rate
-7.78%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Assumes: Buy | $4 | $2.24 | +78.57% | 1 | May 14, 2025 | |
| AFMD Affimed | Downgrades: Neutral | n/a | $0.28 | - | 13 | May 14, 2025 | |
| ITOS iTeos Therapeutics | Downgrades: Neutral | n/a | $7.81 | - | 12 | May 14, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $19.67 | +103.36% | 6 | May 13, 2025 | |
| OCGN Ocugen | Maintains: Buy | $8 → $7 | $0.76 | +823.00% | 21 | May 12, 2025 | |
| VOR Vor Biopharma | Downgrades: Neutral | n/a | $0.18 | - | 12 | May 9, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Buy | $5 → $2 | $0.44 | +357.25% | 15 | May 9, 2025 | |
| PSNL Personalis | Maintains: Buy | $8 → $9 | $4.95 | +81.82% | 15 | May 7, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $150 → $145 | $75.08 | +93.13% | 22 | May 6, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $9 → $4 | $0.37 | +968.66% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $7 | $2.92 | +139.73% | 16 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $2.08 | +428.85% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.49 | +910.51% | 11 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.18 | +154.24% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.74 | +703.95% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.38 | +153.62% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $10.63 | +154.12% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.76 | +979.55% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.40 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $1 | $0.28 | +253.98% | 9 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $20.48 | +22.10% | 18 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.45 | +313.79% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.88 | +143.06% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.21 | +313.22% | 8 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $18.93 | +74.33% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.55 | +89.57% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $0.13 | +4,562.00% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.40 | +362.96% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.30 | +900.00% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $17.10 | +40.35% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.28 | +188.30% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $73.40 | +49.87% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $42.48 | +41.24% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.10 | +307.41% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $1.48 | +271.62% | 6 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.73 | +535.84% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.42 | +1,090.48% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.08 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.05 | +56.03% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.96 | +920.41% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.77 | +224.91% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.84 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.47 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.25 | +620.00% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.05 | +1,119.51% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.75 | +185.67% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.25 | +1,532.65% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.87 | +541.71% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.40 | +4,897.50% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.19 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.56 | +5,028.21% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $3.61 | +66.20% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $7.86 | +90.84% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $7.59 | +334.78% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.96 | -26.70% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.80 | +777,677.78% | 1 | Mar 5, 2020 |
Humacyte
May 14, 2025
Assumes: Buy
Price Target: $4
Current: $2.24
Upside: +78.57%
Affimed
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -
iTeos Therapeutics
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.81
Upside: -
Dianthus Therapeutics
May 13, 2025
Reiterates: Buy
Price Target: $40
Current: $19.67
Upside: +103.36%
Ocugen
May 12, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.76
Upside: +823.00%
Vor Biopharma
May 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.18
Upside: -
ALX Oncology Holdings
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.44
Upside: +357.25%
Personalis
May 7, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $4.95
Upside: +81.82%
Corcept Therapeutics
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $75.08
Upside: +93.13%
Ekso Bionics Holdings
May 6, 2025
Maintains: Buy
Price Target: $9 → $4
Current: $0.37
Upside: +968.66%
May 2, 2025
Maintains: Buy
Price Target: $1.5 → $7
Current: $2.92
Upside: +139.73%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.08
Upside: +428.85%
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $0.49
Upside: +910.51%
Apr 4, 2025
Reiterates: Buy
Price Target: $3
Current: $1.18
Upside: +154.24%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $1.74
Upside: +703.95%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.38
Upside: +153.62%
Apr 1, 2025
Reiterates: Buy
Price Target: $27
Current: $10.63
Upside: +154.12%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.76
Upside: +979.55%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Mar 21, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.28
Upside: +253.98%
Mar 20, 2025
Reiterates: Buy
Price Target: $25
Current: $20.48
Upside: +22.10%
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.45
Upside: +313.79%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.88
Upside: +143.06%
Mar 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.21
Upside: +313.22%
Mar 19, 2025
Reiterates: Buy
Price Target: $33
Current: $18.93
Upside: +74.33%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $10.55
Upside: +89.57%
Mar 14, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.13
Upside: +4,562.00%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.40
Upside: +362.96%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.30
Upside: +900.00%
Mar 7, 2025
Maintains: Buy
Price Target: $22 → $24
Current: $17.10
Upside: +40.35%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $24.28
Upside: +188.30%
Mar 3, 2025
Reiterates: Buy
Price Target: $110
Current: $73.40
Upside: +49.87%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $42.48
Upside: +41.24%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.10
Upside: +307.41%
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $1.48
Upside: +271.62%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $1.73
Upside: +535.84%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.42
Upside: +1,090.48%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.08
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.05
Upside: +56.03%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $1.96
Upside: +920.41%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $2.77
Upside: +224.91%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.84
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.47
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.05
Upside: +1,119.51%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.75
Upside: +185.67%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.25
Upside: +1,532.65%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.87
Upside: +541.71%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.40
Upside: +4,897.50%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.19
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.56
Upside: +5,028.21%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $3.61
Upside: +66.20%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $7.86
Upside: +90.84%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $7.59
Upside: +334.78%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.96
Upside: -26.70%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.80
Upside: +777,677.78%